reglab/housing_qa huggingface dataset:
WA Rev Code § 69.50.570 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.570 - Bundled transactions—Retail sales—Subject to tax—Exception.

RCW 69.50.570 Bundled transactions—Retail sales—Subject to tax—Exception.(1)(a) Except as provided in (b) of this subsection, a retail sale of a bundled transaction that includes marijuana product is subject to the tax imposed under RCW 69.50.535 on the entire selling price of the bundled transaction.(b) If the selling price is attributable to products that are taxable and products that are not taxable under RCW 69.50.535, the portion of the price attributable to the nontaxable products are subject to the tax imposed by RCW 69.50.535 unless the seller can identify by reasonable and verifiable standards the portion that is not subject to tax from its books and records that are kept in the regular course of business for other purposes including, but not limited to, nontax purposes.(2) The definitions in this subsection apply throughout this section unless the context clearly requires otherwise.(a) "Bundled transaction" means:(i) The retail sale of two or more products where the products are otherwise distinct and identifiable, are sold for one nonitemized price, and at least one product is a marijuana product subject to the tax under RCW 69.50.535; and(ii) A marijuana product provided free of charge with the required purchase of another product. A marijuana product is provided free of charge if the sales price of the product purchased does not vary depending on the inclusion of the marijuana product provided free of charge.(b) "Distinct and identifiable products" does not include packaging such as containers, boxes, sacks, bags, and bottles, or materials such as wrapping, labels, tags, and instruction guides, that accompany the retail sale of the products and are incidental or immaterial to the retail sale thereof. Examples of packaging that are incidental or immaterial include grocery sacks, shoeboxes, and dry cleaning garment bags.(c) "Marijuana product" means "useable marijuana," "marijuana concentrates," and "marijuana-infused products" as defined in RCW 69.50.101.(d) "Selling price" has the same meaning as in RCW 82.08.010, except that when product is sold under circumstances where the total amount of consideration paid for the product is not indicative of its true value, "selling price" means the true value of the product sold.(e) "True value" means market value based on sales at comparable locations in this state of the same or similar product of like quality and character sold under comparable conditions of sale to comparable purchasers. However, in the absence of such sales of the same or similar product, "true value" means the value of the product sold as determined by all of the seller's direct and indirect costs attributable to the product.[ 2015 2nd sp.s. c 4 § 210.]NOTES:Findings—Intent—Effective dates—2015 2nd sp.s. c 4: See notes following RCW 69.50.334.
WA Rev Code § 69.50.575 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.575 - Cannabis health and beauty aids.

RCW 69.50.575 Cannabis health and beauty aids.(1) Cannabis health and beauty aids are not subject to the regulations and penalties of this chapter that apply to marijuana, marijuana concentrates, or marijuana-infused products.(2) For purposes of this section, "cannabis health and beauty aid" means a product containing parts of the cannabis plant and which:(a) Is intended for use only as a topical application to provide therapeutic benefit or to enhance appearance;(b) Contains a THC concentration of not more than 0.3 percent;(c) Does not cross the blood-brain barrier; and(d) Is not intended for ingestion by humans or animals.[ 2015 2nd sp.s. c 4 § 701.]NOTES:Findings—Intent—Effective dates—2015 2nd sp.s. c 4: See notes following RCW 69.50.334.
WA Rev Code § 69.50.580 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.580 - Applicants for marijuana producer's, processor's, researcher's, or retailer's licenses—Signage—Public notice requirements.

RCW 69.50.580 Applicants for marijuana producer's, processor's, researcher's, or retailer's licenses—Signage—Public notice requirements.(1) Applicants for a marijuana producer's, marijuana processor's, marijuana researcher's or marijuana retailer's license under this chapter must display a sign provided by the state liquor and cannabis board on the outside of the premises to be licensed notifying the public that the premises are subject to an application for such license. The sign must:(a) Contain text with content sufficient to notify the public of the nature of the pending license application, the date of the application, the name of the applicant, and contact information for the state liquor and cannabis board;(b) Be conspicuously displayed on, or immediately adjacent to, the premises subject to the application and in the location that is most likely to be seen by the public;(c) Be of a size sufficient to ensure that it will be readily seen by the public; and(d) Be posted within seven business days of the submission of the application to the state liquor and cannabis board.(2) The state liquor and cannabis board must adopt such rules as are necessary for the implementation of this section, including rules pertaining to the size of the sign and the text thereon, the textual content of the sign, the fee for providing the sign, and any other requirements necessary to ensure that the sign provides adequate notice to the public.(3)(a) A city, town, or county may adopt an ordinance requiring individual notice by an applicant for a marijuana producer's, marijuana processor's, marijuana researcher's, or marijuana retailer's license under this chapter, sixty days prior to issuance of the license, to any elementary or secondary school, playground, recreation center or facility, child care center, church, public park, public transit center, library, or any game arcade admission to which is not restricted to persons aged twenty-one years or older, that is within one thousand feet of the perimeter of the grounds of the establishment seeking licensure. The notice must provide the contact information for the liquor and cannabis board where any of the owners or operators of these entities may submit comments or concerns about the proposed business location.(b) For the purposes of this subsection, "church" means a building erected for and used exclusively for religious worship and schooling or other activity in connection therewith.[ 2015 2nd sp.s. c 4 § 801.]NOTES:Findings—Intent—Effective dates—2015 2nd sp.s. c 4: See notes following RCW 69.50.334.
WA Rev Code § 69.50.587 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.587 - Cannabis science task force reports—Board rules.

RCW 69.50.587 Cannabis science task force reports—Board rules.The liquor and cannabis board may adopt rules that address the findings and recommendations in the task force reports provided under RCW 43.21A.735.[ 2019 c 277 § 4.]
WA Rev Code § 69.50.601 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.601 - Pending proceedings.

RCW 69.50.601 Pending proceedings.(a) Prosecution for any violation of law occurring prior to May 21, 1971 is not affected or abated by this chapter. If the offense being prosecuted is similar to one set out in Article IV of this chapter, then the penalties under Article IV apply if they are less than those under prior law.(b) Civil seizures or forfeitures and injunctive proceedings commenced prior to May 21, 1971 are not affected by this chapter.(c) All administrative proceedings pending under prior laws which are superseded by this chapter shall be continued and brought to a final determination in accord with the laws and rules in effect prior to May 21, 1971. Any substance controlled under prior law which is not listed within Schedules I through V, is automatically controlled without further proceedings and shall be listed in the appropriate schedule.(d) The commission shall initially permit persons to register who own or operate any establishment engaged in the manufacture, distribution, or dispensing of any controlled substance prior to May 21, 1971 and who are registered or licensed by the state.(e) This chapter applies to violations of law, seizures and forfeiture, injunctive proceedings, administrative proceedings and investigations which occur following May 21, 1971.[ 2013 c 19 § 112; 1971 ex.s. c 308 § 69.50.601.]
WA Rev Code § 69.50.602 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.602 - Continuation of rules.

RCW 69.50.602 Continuation of rules.Any orders and rules promulgated under any law affected by this chapter and in effect on May 21, 1971 and not in conflict with it continue in effect until modified, superseded or repealed.[ 1971 ex.s. c 308 § 69.50.602.]
WA Rev Code § 69.50.603 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.603 - Uniformity of interpretation.

RCW 69.50.603 Uniformity of interpretation.This chapter shall be so applied and construed as to effectuate its general purpose to make uniform the law with respect to the subject of this chapter among those states which enact it.[ 1971 ex.s. c 308 § 69.50.603.]
WA Rev Code § 69.50.604 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.604 - Short title.

RCW 69.50.604 Short title.This chapter may be cited as the Uniform Controlled Substances Act.[ 1971 ex.s. c 308 § 69.50.604.]
WA Rev Code § 69.50.608 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.50 - Uniform Controlled Substances Act.|69.50.608 - State preemption.

RCW 69.50.608 State preemption.The state of Washington fully occupies and preempts the entire field of setting penalties for violations of the controlled substances act. Cities, towns, and counties or other municipalities may enact only those laws and ordinances relating to controlled substances that are consistent with this chapter. Such local ordinances shall have the same penalties as provided for by state law. Local laws and ordinances that are inconsistent with the requirements of state law shall not be enacted and are preempted and repealed, regardless of the nature of the code, charter, or home rule status of the city, town, county, or municipality.[ 1989 c 271 § 601.]
WA Rev Code § 69.51.010 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.010 - Short title.

RCW 69.51.010 Short title.This chapter may be cited as the Controlled Substances Therapeutic Research Act.[ 1979 c 136 § 1.]
WA Rev Code § 69.51.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.020 - Legislative purpose.

RCW 69.51.020 Legislative purpose.The legislature finds that recent research has shown that the use of marijuana may alleviate the nausea and ill effects of cancer chemotherapy and radiology, and, additionally, may alleviate the ill effects of glaucoma. The legislature further finds that there is a need for further research and experimentation regarding the use of marijuana under strictly controlled circumstances. It is for this purpose that the Controlled Substances Therapeutic Research Act is hereby enacted.[ 1979 c 136 § 2.]
WA Rev Code § 69.51.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.030 - Definitions.

RCW 69.51.030 Definitions.As used in this chapter:(1) "Commission" means the pharmacy quality assurance commission;(2) "Department" means the department of health;(3) "Marijuana" means all parts of the plant of the genus Cannabis L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin; and(4) "Practitioner" means a physician licensed pursuant to chapter 18.71 or 18.57 RCW.[ 2013 c 19 § 113; 1989 1st ex.s. c 9 § 438; 1979 c 136 § 3.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.51.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.040 - Controlled substances therapeutic research program.

RCW 69.51.040 Controlled substances therapeutic research program.(1) There is established in the commission the controlled substances therapeutic research program. The program shall be administered by the department. The commission shall promulgate rules necessary for the proper administration of the Controlled Substances Therapeutic Research Act. In such promulgation, the commission shall take into consideration those pertinent rules promulgated by the United States drug enforcement agency, the food and drug administration, and the national institute on drug abuse.(2) Except as provided in RCW 69.51.050(4), the controlled substances therapeutic research program shall be limited to cancer chemotherapy and radiology patients and glaucoma patients, who are certified to the patient qualification review committee by a practitioner as being involved in a life-threatening or sense-threatening situation. No patient may be admitted to the controlled substances therapeutic research program without full disclosure by the practitioner of the experimental nature of this program and of the possible risks and side effects of the proposed treatment in accordance with the informed consent provisions of chapter 7.70 RCW.(3) The commission shall provide by rule for a program of registration with the department of bona fide controlled substance therapeutic research projects.[ 2013 c 19 § 114; 1989 1st ex.s. c 9 § 439; 1979 c 136 § 4.]NOTES:Effective date—Severability—1989 1st ex.s. c 9: See RCW 43.70.910 and 43.70.920.
WA Rev Code § 69.51.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.050 - Patient qualification review committee.

RCW 69.51.050 Patient qualification review committee.(1) The commission shall appoint a patient qualification review committee to serve at its pleasure. The patient qualification review committee shall be comprised of:(a) A physician licensed to practice medicine in Washington state and specializing in the practice of ophthalmology;(b) A physician licensed to practice medicine in Washington state and specializing in the subspecialty of medical oncology;(c) A physician licensed to practice medicine in Washington state and specializing in the practice of psychiatry; and(d) A physician licensed to practice medicine in Washington state and specializing in the practice of radiology.Members of the committee shall be compensated at the rate of fifty dollars per day for each day spent in the performance of their official duties, and shall receive reimbursement for their travel expenses as provided in RCW 43.03.050 and 43.03.060.(2) The patient qualification review committee shall review all applicants for the controlled substance therapeutic research program and their licensed practitioners and certify their participation in the program.(3) The patient qualification review committee and the commission shall insure that the privacy of individuals who participate in the controlled substance therapeutic research program is protected by withholding from all persons not connected with the conduct of the research the names and other identifying characteristics of such individuals. Persons authorized to engage in research under the controlled substance therapeutic research program may not be compelled in any civil, criminal, administrative, legislative, or other proceeding to identify the individuals who are the subjects of research for which the authorization was granted, except to the extent necessary to permit the commission to determine whether the research is being conducted in accordance with the authorization.(4) The patient qualification review committee may include other disease groups for participation in the controlled substances therapeutic research program after pertinent medical data have been presented by a practitioner to both the committee and the commission, and after approval for such participation has been granted pursuant to pertinent rules promulgated by the United States drug enforcement agency, the food and drug administration, and the national institute on drug abuse.[ 2013 c 19 § 115; 1979 c 136 § 5.]
WA Rev Code § 69.51.060 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.060 - Sources and distribution of marijuana.

RCW 69.51.060 Sources and distribution of marijuana.(1) The commission shall obtain marijuana through whatever means it deems most appropriate and consistent with regulations promulgated by the United States food and drug administration, the drug enforcement agency, and the national institute on drug abuse, and pursuant to the provisions of this chapter.(2) The commission may use marijuana which has been confiscated by local or state law enforcement agencies and has been determined to be free from contamination.(3) The commission shall distribute the analyzed marijuana to approved practitioners and/or institutions in accordance with rules promulgated by the commission.[ 2013 c 19 § 116; 1979 c 136 § 6.]
WA Rev Code § 69.51.080 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51 - Controlled Substances Therapeutic Research Act.|69.51.080 - Cannabis and related products considered Schedule II substances.

RCW 69.51.080 Cannabis and related products considered Schedule II substances.(1) The enumeration of tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols in RCW 69.50.204 as a Schedule I controlled substance does not apply to the use of cannabis, tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols by certified patients pursuant to the provisions of this chapter.(2) Cannabis, tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols shall be considered Schedule II substances as enumerated in RCW 69.50.206 only for the purposes enumerated in this chapter.[ 1979 c 136 § 8.]
WA Rev Code § 69.51A.043 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51A - Medical Cannabis.|69.51A.043 - Failure to enter into the medical marijuana authorization database—Affirmative defense.

RCW 69.51A.043 Failure to enter into the medical marijuana authorization database—Affirmative defense.(1) A qualifying patient or designated provider who has a valid authorization from his or her health care professional, but is not entered in the medical marijuana authorization database and does not have a recognition card may raise the affirmative defense set forth in subsection (2) of this section, if:(a) The qualifying patient or designated provider presents his or her authorization to any law enforcement officer who questions the patient or provider regarding his or her medical use of marijuana;(b) The qualifying patient or designated provider possesses no more marijuana than the limits set forth in RCW 69.51A.210(3);(c) The qualifying patient or designated provider is in compliance with all other terms and conditions of this chapter;(d) The investigating law enforcement officer does not have probable cause to believe that the qualifying patient or designated provider has committed a felony, or is committing a misdemeanor in the officer's presence, that does not relate to the medical use of marijuana; and(e) No outstanding warrant for arrest exists for the qualifying patient or designated provider.(2) A qualifying patient or designated provider who is not entered in the medical marijuana authorization database and does not have a recognition card, but who presents his or her authorization to any law enforcement officer who questions the patient or provider regarding his or her medical use of marijuana, may assert an affirmative defense to charges of violations of state law relating to marijuana through proof at trial, by a preponderance of the evidence, that he or she otherwise meets the requirements of RCW 69.51A.040. A qualifying patient or designated provider meeting the conditions of this subsection but possessing more marijuana than the limits set forth in RCW 69.51A.210(3) may, in the investigating law enforcement officer's discretion, be taken into custody and booked into jail in connection with the investigation of the incident.[ 2015 c 70 § 25; 2011 c 181 § 402.]NOTES:Effective date—2015 c 70 §§ 12, 19, 20, 23-26, 31, 35, 40, and 49: See note following RCW 69.50.357.Short title—Findings—Intent—References to Washington state liquor control board—Draft legislation—2015 c 70: See notes following RCW 66.08.012.
WA Rev Code § 69.51A.045 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51A - Medical Cannabis.|69.51A.045 - Possession of plants, marijuana concentrates, useable marijuana, or marijuana-infused products exceeding lawful amount—Affirmative defense.

RCW 69.51A.045 Possession of plants, marijuana concentrates, useable marijuana, or marijuana-infused products exceeding lawful amount—Affirmative defense.(1) A qualifying patient or designated provider in possession of plants, marijuana concentrates, useable marijuana, or marijuana-infused products exceeding the limits set forth in this chapter but otherwise in compliance with all other terms and conditions of this chapter may establish an affirmative defense to charges of violations of state law relating to marijuana through proof at trial, by a preponderance of the evidence, that the qualifying patient's necessary medical use exceeds the amounts set forth in RCW 69.51A.040.(2) An investigating law enforcement officer may seize plants, marijuana concentrates, useable marijuana, or marijuana-infused products exceeding the amounts set forth in this chapter. In the case of plants, the qualifying patient or designated provider shall be allowed to select the plants that will remain at the location. The officer and his or her law enforcement agency may not be held civilly liable for failure to seize marijuana in this circumstance.[ 2015 c 70 § 29; 2011 c 181 § 405.]NOTES:Short title—Findings—Intent—References to Washington state liquor control board—Draft legislation—2015 c 70: See notes following RCW 66.08.012.
WA Rev Code § 69.51A.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.51A - Medical Cannabis.|69.51A.050 - Medical marijuana, lawful possession—State not liable.

RCW 69.51A.050 Medical marijuana, lawful possession—State not liable.(1) The lawful possession or manufacture of medical marijuana as authorized by this chapter shall not result in the forfeiture or seizure of any property.(2) No person shall be prosecuted for constructive possession, conspiracy, or any other criminal offense solely for being in the presence or vicinity of medical marijuana or its use as authorized by this chapter.(3) The state shall not be held liable for any deleterious outcomes from the medical use of marijuana by any qualifying patient.[ 1999 c 2 § 7 (Initiative Measure No. 692, approved November 3, 1998).]